The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 5, p. 2669–2673, 2025. DOI: 10.25251/kj8rwg98. Disponível em: https://skin.dermsquared.com/skin/article/view/3446. Acesso em: 6 nov. 2025.